1. Ida K, Miyamoto T, Takatsu A, Ando H, Asaka R, Takeuchi H, Ono M, Yamada S, Asaka S, Shiozawa T.
Whole-exome sequencing of lobular endocervical glandular hyperplasia.
Oncol Lett. 18(3):2592-2597，2019
2. Nishio S, Mikami Y, Tokunaga H, Yaegashi N, Satoh T, Saito M, Okamoto A, Kasamatsu T, Miyamoto T, Shiozawa T, Yoshioka Y, Mandai M, Kojima A, Takehara K, Kaneki E, Kobayashi H, Kaku T, Ushijima K, Kamura T. Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
Gynecol Oncol. 153(1):13-19，2019
3. Higuchi S, Miyamoto T, Kobara H, Yamada S, Asaka R, Kikuchi N, Kashima H, Ohira S, Shiozawa T.
Trophoblast type-specific expression of senescence markers in the human placenta.
Placenta. 15;85:56-62，2019
4. Ida K, Miyamoto T, Higuchi S, Takeuchi H, Yamada S, Ono M, Nishihara H, Shiozawa T.
Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study.
Med Oncol. 36(7):62，2019
5. Ida K, Yamanoi K, Asaka S, Takeuchi H, Miyamoto T, Shiozawa T, Nakayama J.
αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type.
Sci Rep. 9(1):13043，2019
6. Miyamoto T, Shiozawa T.
Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor?
Gynecol Endocrinol. 35(5):370-375，2019
7. Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H.
Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Virchows Arch. 474(1):79-86，2019
8. Ohira S, Yamanaka S, Asaka R, Ando H, Fuseya C, Kikuchi N, Miyamoto T, Kanai M, Shiozawa T.
Sawtooth fetal heart rate pattern associated with a favorable neurological outcome in an infant: a case report.
J Med Case Rep. 13(1):226，2019
9. Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Kato T, Takahashi K, Ariyoshi K, Suzuki K, Arimoto T, Matsumoto Y, Nakai H, Inoue T, Yokoyama M, Kawabata T, Kodama S, Miyamoto T, Takano M, Yaegashi N.
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
Gynecol Oncol. 155(3):444-451，2019.
10. Asaka R, Le A.
Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy.
Mol Cell Oncol. 6(5):e1627273. 2019.
11. Udupa S, Nguyen S, Hoang G, Nguyen T, Quinones A, Pham K, Asaka R, Nguyen K, Zhang C, Elgogary A, Jung JG, Xu Q, Fu J, Thomas AG, Tsukamoto T, Hanes J, Slusher BS, Cooper AJL, Le A.
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
Proteomics. 19(21-22):e1800451. 2019.
12. Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, Antonio MJ, Camelo F, Li T, Nguyen S, Hoang G, Nguyen K, Udupa S, Sazeides C, Shen YA, Elgogary A, Reyes J, Zhao L, Kleensang A, Chaichana KL, Hartung T, Betenbaugh MJ, Marie SK, Jung JG, Wang TL, Gabrielson E, Le A.
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.
Cell Rep. 27(2):491-501.e6. 2019.
13. Uehara M, Nakamura Y, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, KoshoT, Kato H.
Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report.
Ther Clin Risk Manag.15:303-307. 2019
